ProteinLogic Ltd
Entity

  • ProteinLogic Ltd

  • BETA

    To investigate (B)
    Some signals may appear as inconsistent with a regular activity

  • Social networks

    81

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Shakespeare House, 42 Newmarket Rd, Cambridge CB5 8EP, UK

    Cambridge

    United Kingdom

  • Employees

    Scale: 2-10

    Estimated: 1

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    5 months, 2 weeks ago
Description
  • Value proposition

    ProteinLogic has developed a novel technology platform (ImmiPrint®) focused on the diagnosis of tuberculosis (TB). Along with HIV/AIDS, TB is the most significant infectious disease worldwide. Early and accurate diagnosis is essential for its control.

    The ImmiPrint® platform has the potential to deliver an effective blood-based TB diagnostic, and to provide information on disease progression. The test may also be able to predict which individuals are likely to respond to anti-microbial therapy.

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics